Oxford BioDynamics (LON:OBD) Shares Cross Below Fifty Day Moving Average – Here’s What Happened

Oxford BioDynamics Plc (LON:OBD) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 0.12 and traded as low as GBX 0.11. Oxford BioDynamics shares last traded at GBX 0.11, with a volume of 101,577,781 shares changing hands.

Oxford BioDynamics Stock Performance

The company has a quick ratio of 2.80, a current ratio of 2.01 and a debt-to-equity ratio of 131.61. The stock has a market cap of £4.93 million, a P/E ratio of -0.57 and a beta of 0.42. The stock has a fifty day simple moving average of GBX 0.12 and a 200-day simple moving average of GBX 0.17.

Oxford BioDynamics (LON:OBD) last issued its quarterly earnings data on Tuesday, June 30th. The biotechnology company reported GBX (0.10) earnings per share (EPS) for the quarter. Oxford BioDynamics had a negative net margin of 825.61% and a negative return on equity of 451.74%.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.